Neurology Exchange:
Exploring the Latest Advances in Multiple Sclerosis Diagnosis and Management

A CME/CE series of Live Grand Rounds Programs and an on-demand Webcourse

Welcome to "Neurology Exchange: Exploring the Latest Advances in Multiple Sclerosis Diagnosis and Management".

A series of live CME/CE-certified activities will be presented at selected hospitals throughout the US during 2013/2014, and a CME/CE-certified on-demand webcourse will be available in February 2014.

Program Description:

The Potomac Center for Medical Education and Rockpointe welcome you to Exploring the Latest Advances in Multiple Sclerosis Diagnosis and Management, a CME/CE-certified Neurology Exchange program designed to give medical professionals the latest news and information on the diagnosis and management of MS.

Disease-modifying drugs (DMDs) – which reduce relapse rate, decrease development of lesions, slow disease progression, and improve quality of life in MS – have become the mainstay of therapy over the last 20 years. Despite recommendations from various MS experts and groups – including the National Multiple Sclerosis Disease Management Consensus Statement, which recommends initiating a DMD as soon after definitive diagnosis as possible and considering DMD therapy in select high-risk patients with a first attack – the initiation of this treatment is frequently delayed or skipped entirely. Increasingly, earlier diagnosis and initiation of therapy is found to delay disability and lessen the overall impact of MS. However, this push toward early management has made decision-making more complex for clinicians.

Exploring the Latest Advances in Multiple Sclerosis Diagnosis and Management will provide guidance on early, individualized treatment to help clinicians optimize adherence and improve outcomes for patients with MS.

Target Audience:

This CME/CE-certified initiative is intended for neurologists and other health care providers actively involved in the care of patients with multiple sclerosis (MS).

Accreditation Statements:

Physicians - This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Nurses - Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statements:

Physicians - The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For information about the accreditation of this program, please email contact@rockpointe-pcme.com.

Nurses - This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity. For information about the nursing accreditation of this program, please contact Global at inquire@globaleducationgroup.com or 303-395-1782.

Calendars of Live Activities

Back to Top

Visiting Professor Series

Related Online Offerings

Back to Top

A calendar of live events, as well as additional CME-certified online activities, for this and other Neurology Exchange programming is available at: (available in February 2014).

Live Program Materials for Speakers and Administrators

Back to Top

I. Administrator Material

II. Speaker Material

Audio Orientation

Thank you for joining us as an expert speaker for the 2013-14 Visiting Professor Series, "Neurology Exchange: Exploring the Latest Advances in Multiple Sclerosis Diagnosis and Management."

This orientation will familiarize you with the complete slide set, provide insight from the program steering committee, and address potential questions. The following key topics will be discussed:

  • Select the most appropriate DMD therapies that can be used to initiate treatment earlier in the disease course
  • Develop individualized treatment plans to optimize adherence and improve outcomes in patients with MS
  • Describe how emerging biomarkers and newer MRI measures improve the accuracy of diagnosis and monitoring of MS disease activity

Transcript of Speaker Orientation Download (PDF) (Coming Soon)

Audio download of Speaker Orientation (ComingSoon)

Audio Download

CME/CE-certified Program Slides

This version of the program slides has been CME/CE-certified and these slides are to be used for this activity. Download (PowerPoint)

Disclosure Information:

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

FDA Disclosure:

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information or full disclosure of approved uses.

Steering Committee

Back to Top

Suhayl Dhib-Jalbut, MDSuhayl Dhib-Jalbut, MD
Professor and Chairman, Department of Neurology
Rutgers-Robert Wood Johnson Medical School
Chief, Neurology Service
Robert Wood Johnson University Hospital
New Brunswick, NJ


Suhayl Dhib-Jalbut, MD is Professor and Chairman of the Department of Neurology at RUTGERS-Robert Wood Johnson Medical School, and Chief of Neurology at the Robert Wood Johnson University Hospital. He is also Director of the RWJ Center for Multiple Sclerosis (MS).

Dr. Dhib-Jalbut graduated Alpha-Omega-Alpha from the American University of Beirut in Lebanon and completed his neurology training at the University of Cincinnati. He then joined the National Institutes of Health (NIH) in Bethesda, MD, where he specialized in MS and neuroimmunology. Dr. Dhib-Jalbut joined the faculty of the University of Maryland in Baltimore in July 1990 and established a research program in MS before his recruitment to Robert Wood Johnson Medical School in 2003.

Dr. Dhib-Jalbut's research, which has been funded by the NIH, the National MS Society, and industry sources, includes how MS therapies work, biomarkers of treatment response in MS, and neuroprotective gene therapy. Dr. Dhib-Jalbut published more than 100 manuscripts in the scientific literature. He served as Associate Editor for the Journal of Neuroimmunology. He currently serves on the Editorial Boards of JICR and MS International. He served on several national and international scientific committees, including as Chairman of the Scientific Committee for the World Congress on MS in 2008. Dr. Dhib-Jalbut has been on the Best Doctors in America list since 2009 and has received several awards and recognitions. Most recently, he was awarded the Norman H. Edelman clinical science mentoring award at RUTGERS, the Medical Excellence Award by the National MS Society NJ Metro Chapter, and the Edward Ill Award for Excellence in clinical research in the State of New Jersey. Dr. Dhib-Jalbut currently serves as President of the Americas Committee for Treatment and Research in MS (ACTRIMS).


Aaron E. Miller, MDAaron E. Miller, MD
Professor of Neurology
Medical Director
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai Medical Center
New York, NY


Aaron E. Miller, MD is Professor of Neurology at Mount Sinai School of Medicine and Medical Director at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis. He is widely recognized for his preeminence as an MS clinician and thought leader. Dr. Miller graduated from Brandeis University in 1964 and received his medical doctorate from New York University School of Medicine in 1968. Following his residency in neurology at the Albert Einstein College of Medicine, he received additional postdoctoral training in neurovirology and immunology at Albert Einstein College of Medicine, as well as the Johns Hopkins University School of Hygiene and Public Health. During this time, he was the recipient of a fellowship from the National MS Society. In March, 2004, Dr. Miller assumed the position of Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Mount Sinai School of Medicine. For 23 years prior to that, he headed the Division of Neurology at Maimonides Medical Center in Brooklyn, NY where he continues to serve as Co-director of the MS Care Center.

Dr. Miller has been the Chief Medical Officer of the National MS Society since October 2001 and served as Chairman of the National Medical Advisory Board of the NMSS from 2001-2009. He has been a member of the NMSS Board of Directors since 2003. He was Chairman of the Clinical Advisory Committee of the New York Chapter of the NMSS from 1991-2004. He was Chairman of the Professional Education Committee of the NMSS and is a Past President of the Consortium of MS Centers. He was the first Chairman of the Multiple Sclerosis section of the American Academy of Neurology.

Dr. Miller is active with the American Academy of Neurology, and is a member of the Board of Directors. He was Editor of Continuum, their bimonthly continuing education publication, from 2003 through 2012, and continues to serve as Editor of Continuum Audio. Dr. Miller has served as the Principal Investigator for many clinical trials in MS and has been a member of many data and safety monitoring boards.

Robert T. Naismith, MDRobert T. Naismith, MD
Assistant Professor of Neurology
Washington University
St. Louis, MO


Robert T. Naismith, MD is Assistant Professor of Neurology at Washington University in St. Louis. As a Clinical Investigator, his interests include Quantitative Imaging and Clinical Outcome Measures. After receiving an MS Fellowship Training Award from the National MS Society, he has been funded by the NIH to study Diffusion Tensor Imaging in the Optic Nerve. He has authored more than 30 publications in journals such as Brain, Neurology, Archives of Neurology, and Multiple Sclerosis.

Dr. Naismith directs the John L. Trotter MS Center at Washington University, which is a multi-disciplinary MS center with comprehensive care, clinical trials, and clinical and basic science investigations. Dr. Naismith is also the Neurology Clerkship Director for the 3rd Year Medical Students and oversees the weekly Resident Evidence-based Journal Club. He serves as Chair of the Clinical Advisory Committee for the local NMSS, in addition to their Chapter Program and Service Committee, and as the Chapter Research Advocate. He also serves on the Steering Committee of ACTRIMS.

Back to Top

JOINTLY SPONSORED BY

CO-PROVIDED BY

SUPPORTED BY

Supported by an educational grant from:
©2013 Rockpointe